ad

Hannah Joseph Hospital IPO GMP & Subscription Status: Day 1 IPO Live Updates

Posted by : sachet | Thu Jan 22 2026

Hannah Joseph Hospital IPO GMP & Subscription Status: Day 1 IPO Live Updates

The Hannah Joseph Hospital IPO GMP is ₹0 as of 22nd January 2026. It is a book-building issue IPO of ₹42.00 crores. This is an entirely fresh issue of 0.60 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 30th January 2026. The face value of Hannah Joseph Hospital IPO shares is ₹10 per share, and the IPO price band is ₹67 to ₹70 per share. Retail investors can bid for a minimum of 2 lots of 4,000 shares worth ₹2,80,000. Scroll down to check the Hannah Joseph Hospital IPO GMP and subscription details.

Hannah Joseph Hospital IPO GMP Grey Market Premium

As mentioned earlier, the Hannah Joseph Hospital IPO GMP currently stands at ₹0.00 per share. Thus, the estimated listing price would be at ₹70.00. This indicates that the estimated listing gain in this IPO could be 0.00%. Explore the table for Hannah Joseph Hospital IPO GMP updates.

GMP DATEIPO PriceGMP PriceEstimated Listing PriceEstimated Gain
22-01-2026₹70.00₹0.00₹70.000.00%
21-01-2026₹70.00₹0.00₹70.000.00%
20-01-2026₹70.00₹0.00₹70.000.00%
19-01-2026₹70.00₹0.00₹70.000.00%
18-01-2026₹70.00₹0.00₹70.000.00%
17-01-2026₹70.00₹0.00₹70.000.00%
16-01-2026₹70.00₹0.00₹70.000.00%
15-01-2026₹70.00₹0.00₹70.000.00%
14-01-2026₹70.00₹0.00₹70.000.00%
13-01-2026₹70.00₹0.00₹70.000.00%

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Hannah Joseph Hospital IPO GMP status at Univest.

Click and Sign Up to Get Live Updates on Hannah Joseph Hospital IPO GMP Status

Hannah Joseph Hospital IPO Subscription Status

As of now, the Hannah Joseph Hospital IPO has been subscribed to 0.02 times. Of these, 0.02 times are subscribed by retail investors, 0.04 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of Hannah Joseph Hospital’s IPO listing on 30th January 2026. Hannah Joseph Hospital also has a positive outlook behind the fresh issue of 0.60 crore shares, which will raise around Rs 42.00 crores.

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Hannah Joseph Hospital IPO Subscription status at Univest.

Click and Sign Up to Get Live Updates on Hannah Joseph Hospital IPO Subscription Status

Hannah Joseph Hospital IPO Details

IPO Allotment Date28th January 2026
IPO Open Date22nd January 2026
IPO Close Date27th January 2026
Refund Initiation 29th January 2026
Issue Size60,00,000 shares(agg. up to ₹42 Cr)
Face Value₹10 per share
Lot Size2,000 Shares
Issue Price ₹67 to ₹70 per share
Issue TypeBookbuilding IPO
Listing AtBSE SME
Listing Date30th January 2026

Also Read: Hannah Joseph Hospital IPO GMP & Review: Apply or Avoid?

Explanation

Hannah Joseph Hospital IPO: Hannah Joseph Hospital IPO Limited has declared an issue price band of ₹67 to ₹70 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 4,000 shares, each worth ₹2,80,000. The face value of Hannah Joseph Hospital IPO Limited shares is ₹10 per share. The shares of Hannah Joseph Hospital IPO Limited will be listed on BSE and SME on its tentative listing day, 30th January 2026. Scroll down to check GMP updates and Hannah Joseph Hospital IPO reviews. 

About Hannah Joseph Hospital Ltd.

Hannah Joseph Hospital Limited was established in 2011. Hannah Joseph Hospital Limited is a healthcare provider offering exceptional medical services across various specialities. The company is a multi-speciality healthcare provider in Madurai, situated on a 2-acre campus with a central air-conditioning and water heating system, offering a combined capacity of 150 beds. The company focuses on Neurology, Cardiology, Psychiatry, and Trauma healthcare, understanding global nuances, customer culture, and medical professionals’ needs, addressing the demand for quality and affordable healthcare services

Services:

  • Department of Neurosciences: Neurology, Neurosurgery
  • Department of Cardio Sciences: Cardiology
  • Department of Trauma Care: Orthopaedics, Oral & Maxillofacial Surgery
  • Department of Psychiatry: Psychiatry

As of November 30, 2025, the company has 364 employees.

Hannah Joseph Hospital Limited Financials

The company’s financial analysis is essential before applying for the Hannah Joseph Hospital IPO. Look at the table to learn about Hannah Joseph Hospital Limited’s financials. 

Year Ended30th Sep 2025 (in cr.)31st March 2025 (in cr.)31st March 2024 (in cr.)31st March 2023 (in cr.)
Assets104.5899.2989.9792.14
Revenue42.7577.9063.6354.90
Profit After Tax5.127.214.071.01
EBITDA11.6520.5217.9816.38
Net Worth53.2248.9343.9334.15
Reserves and Surplus40.3635.2429.0218.20
Total Borrowings31.6433.5831.3942.95

Explanation

Hannah Joseph Hospital Limited’s revenue increased by 51.70% from ₹63.63 crores in March 2024 to ₹77.90 crores in March 2025. Moreover, the company’s PAT increased by 41.52% from ₹4.70 crores in March 2024 to ₹7.21 crores in March 2025.

Hannah Joseph Hospital IPO Objectives

The primary aim of the Hannah Joseph Hospital IPO is to raise ₹42.00 crores. On the other hand, Hannah Joseph Hospital has decided to utilise these funds in different ways.

  • To fund capital expenditure for establishing the Radiation Oncology Centre
  • To General Corporate Expenses.

Hannah Joseph Hospital IPO Registrar

Bigshare Services Private Limited is the registrar for the Hannah Joseph Hospital IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Hannah Joseph Hospital allotment and refund, you can contact Bigshare Services Private Limited at ipo@bigshareonline.com or at +91-22-6263 8200.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces! 

Hannah Joseph Hospital IPO Review

Hannah Joseph Hospital IPO Review

The Hannah Joseph Hospital IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Hannah Joseph Hospital Limited’s revenue increased by 51.70% from ₹63.63 crores in March 2024 to ₹77.90 crores in March 2025. Moreover, the company’s PAT increased by 41.52% from ₹4.70 crores in March 2024 to ₹7.21 crores in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Hannah Joseph Hospital IPO or not.

Key IndicatorsValue
PE Ratio (Price-to-Earnings) 16.21
EPS (Earnings Per Share)4.32
RoNW9.62%
ROCE10.41%
ROE9.39%
EBITDA Margin27.38
Price to Book Value2.20
Market Capitalisation₹158.89 Cr

The P/E ratio of Hannah Joseph Hospital Limited shares is 16.21, and its Earnings Per Share (EPS) stands at 4.32. Thus, the Hannah Joseph Hospital IPO can deliver gains on its tentative listing date, 30th January 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Hannah Joseph Hospital Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

IndicatorsPre-IPOPost-IPO
PE Ratio16.2115.52
EPS 4.324.51

FAQs on Hannah Joseph Hospital IPO

What is the Hannah Joseph Hospital IPO GMP?

Currently, on 22nd January 2026, the Hannah Joseph Hospital IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹70.00 per share.

What is the issue price of the Hannah Joseph Hospital IPO?

The Hannah Joseph Hospital IPO issue price band is set at ₹67.00 to ₹70.00 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 4,000 shares, worth ₹2,80,000. Moreover, HNIs are required to bid for a minimum of 3 lots (6,000 shares) worth ₹4,20,000.

Who is the registrar of the Hannah Joseph Hospital IPO?

Bigshare Services Private Limited is the registrar for the Hannah Joseph Hospital IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Hannah Joseph Hospital allotment and refund, you can contact Bigshare Services Private Limited at ipo@bigshareonline.com or at +91-22-6263 8200.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Hannah Joseph Hospital IPO, download the Hannah Joseph Hospital IPO RHP and Hannah Joseph Hospital IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Aritas Vinyl IPO GMP & Subscription Status: Day 2

Digilogic Systems IPO

Hannah Joseph Hospital IPO

Defrail Technologies IPO Listing Today

Bharat Coking Coal IPO Listing Today

icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
General
arrow down